What IVF laboratory technology does IGIN use? expand_more
IGIN’s IVF laboratory is equipped with state‑of‑the‑art time‑lapse incubators (Embryoscope+) that continuously monitor embryo development without disturbing culture conditions. Embryos are evaluated using advanced artificial‑intelligence algorithms, including IDAScore and KIDScore, which compare morphological patterns against a global database to predict implantation potential. The clinic also employs laser‑assisted hatching, vitrification devices for embryo and oocyte cryopreservation, and the EmbryoGlue medium to enhance embryo‑uterine adhesion. Additional technologies include plasma‑rich‑platelet (PRP) therapy for endometrial receptivity and a full suite of ICSI equipment for precise sperm injection. All laboratory processes adhere to strict quality certifications and are audited by the Spanish Fertility Society, ensuring high standards of safety and efficacy.
What is the maximum age for IVF treatment at IGIN? expand_more
IGIN sets age limits based on the specific treatment: for ovodonation cycles, women up to 44 years are accepted, while IVF‑ICSI with own eggs is typically offered to women under 44 years who have adequate ovarian reserve. Intrauterine insemination with donor sperm is recommended for women under 37 years, reflecting optimal success probabilities. The clinic evaluates each patient individually, considering hormonal profiles, ovarian reserve, and overall health, and may extend treatment beyond these thresholds in select cases with thorough counseling. These age policies align with IGIN’s commitment to maximizing pregnancy rates while ensuring patient safety.
What fertility treatments and services does IGIN offer? expand_more
IGIN provides a comprehensive suite of assisted reproduction options, including IVF‑ICSI, Pre‑implantation Genetic Diagnosis (PGD), ovodonación, double donation (both egg and sperm donors), and the ROPA method for shared motherhood among female couples. The clinic also offers intrauterine insemination (IUI) with partner or donor sperm, artificial insemination, vitrified embryo transfer, and fertility preservation through egg freezing. Specialized services such as plasma‑rich‑platelet (PRP) endometrial support, laser‑assisted hatching, and AI‑based embryo selection are integrated into treatment plans. IGIN tailors each protocol to the patient’s age, ovarian reserve, and reproductive history, ensuring that every individual or couple receives a personalized, evidence‑based fertility solution.
Does IGIN offer egg donation for IVF treatment? expand_more
Yes, IGIN provides a full ovodonation program for patients who cannot use their own oocytes due to age, ovarian failure, genetic conditions, or previous treatment failures. The clinic maintains an extensive, screened donor bank and matches donors to recipients based on genetic compatibility and phenotypic characteristics. Donor eggs are fertilized using ICSI and cultured to the blastocyst stage before transfer. IGIN reports an 88% pregnancy rate for ovodonation cycles, reflecting the high quality of donor gametes and the clinic’s optimized laboratory protocols. Comprehensive counseling, legal compliance, and personalized treatment planning ensure a safe and effective egg donation experience.
What are the IVF success rates at IGIN? expand_more
IGIN reports a pregnancy rate of 79% per embryo transfer for its IVF‑ICSI cycles, which is more than double the national average of 34%. The clinic also achieves a 86% success rate for cycles that include Pre‑implantation Genetic Diagnosis (PGD) and an 88% rate for ovodonation cycles, both audited by the Spanish Society of Fertility. These figures reflect the use of advanced laboratory protocols, personalized ovarian stimulation, and AI‑driven embryo selection, all of which contribute to high implantation and pregnancy outcomes. IGIN’s results are based on cumulative data from a single treatment cycle and are regularly verified by an independent third‑party audit, underscoring the clinic’s commitment to transparent and reliable IVF success reporting.
Does IGIN treat single women seeking fertility treatment? expand_more
IGIN welcomes single women who wish to become mothers and offers a range of tailored options, including IVF‑ICSI with donor sperm, artificial insemination with donor semen, and egg freezing for future use. The clinic’s protocols specify that women without a partner should be under 37 years for artificial insemination and can undergo IVF‑ICSI with donor sperm regardless of age, provided they meet ovarian reserve criteria. Comprehensive medical, psychological, and legal support is provided throughout the journey, ensuring that solo mothers receive the same high‑quality care and success rates as couples. IGIN’s inclusive approach reflects its commitment to supporting diverse family‑building paths.
Does IGIN provide fertility treatment for same‑sex couples? expand_more
IGIN offers dedicated fertility solutions for same‑sex couples, most notably the ROPA (Reception of Ovocytes from the Partner) method, which enables two women to share genetic and gestational roles in a single pregnancy. The clinic also provides IVF‑ICSI with donor sperm for lesbian couples, as well as insemination and egg donation options. Services are designed to address the unique medical and legal considerations of female and male same‑sex partnerships, with experienced reproductive endocrinologists and embryologists guiding each step. IGIN’s inclusive policies and high success rates—79% for ROPA cycles—demonstrate its expertise in creating families for LGBTQ+ patients.
What is the history and background of IGIN? expand_more
Founded as a leading reproductive medicine center in Spain, IGIN has grown to serve more than 20,000 patients from over 110 countries. The clinic’s success rates consistently exceed national averages, a performance validated by audits from the Spanish Society of Fertility. IGIN has expanded its footprint with clinics in Bilbao, Vitoria, Donostia, Santander, Salamanca, and upcoming locations in Madrid and Pamplona slated for 2025. The institution combines cutting‑edge technology with a multidisciplinary team of reproductive endocrinologists, embryologists, and nursing specialists. Recognized for its high pregnancy rates across IVF‑ICSI, PGD, and ovodonation, IGIN continues to invest in research, AI‑driven embryo selection, and patient‑centered care, positioning itself as a benchmark for excellence in assisted reproduction.
